These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8723481)

  • 1. Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptases.
    Cherrington JM; Fuller MD; Mulato AS; Allen SJ; Kunder SC; Ussery MA; Lesnikowski Z; Schinazi RF; Sommadossi JP; Chen MS
    Antimicrob Agents Chemother; 1996 May; 40(5):1270-3. PubMed ID: 8723481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
    Ueno T; Mitsuya H
    Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate.
    Yang G; Wang J; Cheng Y; Dutschman GE; Tanaka H; Baba M; Cheng YC
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2035-42. PubMed ID: 18391035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
    Gu Z; Fletcher RS; Arts EJ; Wainberg MA; Parniak MA
    J Biol Chem; 1994 Nov; 269(45):28118-22. PubMed ID: 7525567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitro.
    Cherrington JM; Mulato AS; Fuller MD; Chen MS
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2212-6. PubMed ID: 8878611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
    Shi M; Wang X; De Clercq E; Takao S; Baba M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2600-4. PubMed ID: 17470654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice.
    Black Pl; Ussery MA; Barney S; Wittrock R; DeMarsh P; Dreyer GB; Petteway SR; DalMonte P; Baldoni J; Lambert D
    Antiviral Res; 1996 Mar; 29(2-3):175-86. PubMed ID: 8739597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
    Suo Z; Johnson KA
    J Biol Chem; 1998 Oct; 273(42):27250-8. PubMed ID: 9765248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase.
    Feng JY; Murakami E; Zorca SM; Johnson AA; Johnson KA; Schinazi RF; Furman PA; Anderson KS
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1300-6. PubMed ID: 15047533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
    Krebs R; Immendörfer U; Thrall SH; Wöhrl BM; Goody RS
    Biochemistry; 1997 Aug; 36(33):10292-300. PubMed ID: 9254628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.
    Auwerx J; North TW; Preston BD; Klarmann GJ; De Clercq E; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):400-6. PubMed ID: 11809865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.
    Ndongwe TP; Adedeji AO; Michailidis E; Ong YT; Hachiya A; Marchand B; Ryan EM; Rai DK; Kirby KA; Whatley AS; Burke DH; Johnson M; Ding S; Zheng YM; Liu SL; Kodama E; Delviks-Frankenberry KA; Pathak VK; Mitsuya H; Parniak MA; Singh K; Sarafianos SG
    Nucleic Acids Res; 2012 Jan; 40(1):345-59. PubMed ID: 21908397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.
    Sluis-Cremer N; Sheen CW; Zelina S; Torres PS; Parikh UM; Mellors JW
    Antimicrob Agents Chemother; 2007 Jan; 51(1):48-53. PubMed ID: 17088490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological Mg
    Achuthan V; Singh K; DeStefano JJ
    Biochemistry; 2017 Jan; 56(1):33-46. PubMed ID: 27936595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
    Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
    Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
    Freeman GA; Rideout JL; Miller WH; Reardon JE
    J Med Chem; 1992 Aug; 35(17):3192-6. PubMed ID: 1380561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
    Im GJ; Tramontano E; Gonzalez CJ; Cheng YC
    Biochem Pharmacol; 1993 Dec; 46(12):2307-13. PubMed ID: 7506027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-human immunodeficiency virus type 1 (HIV-1) activity of 3-substituted derivatives of 3'-azido-3'-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5'-triphosphates.
    Kitade Y; Suzuki A; Hirota K; Maki Y; Nakane H; Ono K; Baba M; Shigeta S
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):920-4. PubMed ID: 1381996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.